======= RCC2 ======= == Gene Information == * **Official Symbol**: RCC2 * **Official Name**: regulator of chromosome condensation 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55920|55920]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9P258|Q9P258]] * **Interactions**: [[https://thebiogrid.org/search.php?search=RCC2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RCC2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609587|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is a guanine exchange factor that is active on RalA, a small GTPase. The encoded protein and RalA are both essential for proper kinetochore-microtubule function in early mitosis. This protein has been shown to be a biomarker for colorectal cancer. [provided by RefSeq, Oct 2016]. * **UniProt Summary**: Required for completion of mitosis and cytokinesis. May function as a guanine nucleotide exchange factor for the small GTPase RAC1. {ECO:0000269|PubMed:12919680}. |RCC1| |chromosome, centromeric core domain| |chromosome passenger complex localization to kinetochore| |positive regulation of attachment of spindle microtubules to kinetochore| |regulation of attachment of spindle microtubules to kinetochore| |negative regulation of substrate adhesion-dependent cell spreading| |protein localization to kinetochore| |mitotic spindle midzone| |protein localization to chromosome, centromeric region| |negative regulation of focal adhesion assembly| |negative regulation of adherens junction organization| |small GTPase binding| |negative regulation of cell junction assembly| |cellular protein-containing complex localization| |positive regulation of G2/M transition of mitotic cell cycle| |focal adhesion assembly| |cell-substrate adherens junction assembly| |positive regulation of chromosome segregation| |regulation of ruffle assembly| |positive regulation of cell cycle G2/M phase transition| |regulation of fibroblast migration| |adherens junction assembly| |negative regulation of cell-matrix adhesion| |cell-substrate junction assembly| |negative regulation of GTPase activity| |regulation of substrate adhesion-dependent cell spreading| |Rac GTPase binding| |regulation of cell-substrate junction assembly| |regulation of focal adhesion assembly| |negative regulation of cell-substrate adhesion| |protein localization to chromosome| |regulation of adherens junction organization| |positive regulation of mitotic cell cycle phase transition| |adherens junction organization| |regulation of cell junction assembly| |positive regulation of cell cycle phase transition| |integrin-mediated signaling pathway| |activation of GTPase activity| |negative regulation of cell morphogenesis involved in differentiation| |regulation of chromosome segregation| |guanyl-nucleotide exchange factor activity| |regulation of cell-matrix adhesion| |cell-matrix adhesion| |positive regulation of mitotic cell cycle| |early endosome membrane| |midbody| |cell junction assembly| |cell-substrate adhesion| |regulation of G2/M transition of mitotic cell cycle| |regulation of plasma membrane bounded cell projection assembly| |regulation of cell projection assembly| |regulation of cell cycle G2/M phase transition| |regulation of cell-substrate adhesion| |cell junction organization| |microtubule binding| |protein domain specific binding| |protein-containing complex localization| |negative regulation of cell adhesion| |positive regulation of cell cycle process| |regulation of cell morphogenesis involved in differentiation| |microtubule| |negative regulation of cell development| |positive regulation of cell cycle| |regulation of mitotic cell cycle phase transition| |positive regulation of GTPase activity| |regulation of cell cycle phase transition| |negative regulation of hydrolase activity| |protein kinase binding| |regulation of GTPase activity| |regulation of cell morphogenesis| |cell division| |regulation of mitotic cell cycle| |regulation of cell adhesion| |regulation of plasma membrane bounded cell projection organization| |negative regulation of cellular component organization| |regulation of cell projection organization| |negative regulation of cell differentiation| |protein localization to organelle| |regulation of cell cycle process| |positive regulation of hydrolase activity| |negative regulation of catalytic activity| |regulation of cell migration| |nucleolus| |regulation of cell motility| |cell adhesion| |regulation of cell development| |biological adhesion| |negative regulation of developmental process| |regulation of cellular component biogenesis| |regulation of locomotion| |regulation of cellular component movement| |regulation of anatomical structure morphogenesis| |negative regulation of molecular function| |regulation of cell cycle| |regulation of hydrolase activity| |cell cycle| |RNA binding| |positive regulation of catalytic activity| |cellular protein localization| |cellular macromolecule localization| |establishment of protein localization| |positive regulation of molecular function| |regulation of cell differentiation| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp189|Temozolomide 200μM R04 exp189]]|-2.65| |[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|-2.27| |[[:results:exp512|Olaparib 4μM R08 exp512]]|-2.12| |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|-2.11| |[[:results:exp215|Colchicine 0.009μM R05 exp215]]|-1.97| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|-1.75| |[[:results:exp536|Vitamin-D3 40μM R08 exp536]]|1.7| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|1.73| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|1.79| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|1.85| |[[:results:exp183|IU1-C 25μM R04 exp183]]|1.86| |[[:results:exp335|Aminopterin 0.005μM R07 exp335]]|2.11| |[[:results:exp470|Chloroquine 32μM R08 exp470]]|2.11| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|2.11| |[[:results:exp128|GSK591 2.6μM R03 exp128]]|2.17| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 7551 * **Expression level (log2 read counts)**: 8.92 {{:chemogenomics:nalm6 dist.png?nolink |}}